260 related articles for article (PubMed ID: 32938456)
1. Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2.
Tao Y; Yang R; Shu J; Zheng W; Chen J; Wu Y; He Y
BMC Vet Res; 2020 Sep; 16(1):342. PubMed ID: 32938456
[TBL] [Abstract][Full Text] [Related]
2. Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and
Tao Y; Li G; Zheng W; Shu J; Chen J; Yang F; Wu Y; He Y
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505747
[No Abstract] [Full Text] [Related]
3. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
Park C; Jeong J; Choi K; Chae C
Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
[TBL] [Abstract][Full Text] [Related]
5. Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and
Yang S; Park SJ; Oh T; Cho H; Chae C
Can J Vet Res; 2020 Oct; 84(4):272-282. PubMed ID: 33012976
[TBL] [Abstract][Full Text] [Related]
6. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
[TBL] [Abstract][Full Text] [Related]
7. Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae.
Wang Y; Wang J; Zhou M; Liu P; Zhang E; Li Y; Lin J; Feng Z; Yang Q
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31492763
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses induced in mice immunized with recombinant adenovectors expressing chimeric proteins of various porcine pathogens.
Roques E; Girard A; Gagnon CA; Archambault D
Vaccine; 2013 May; 31(24):2698-704. PubMed ID: 23583895
[TBL] [Abstract][Full Text] [Related]
9. Oral Immunization with Attenuated
Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
[TBL] [Abstract][Full Text] [Related]
11. Immunoenhancement of Recombinant Neisseria meningitides PorB Protein on Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae Genetically Engineered Vaccines.
Yang R; Tao Y; Li G; Chen J; Shu J; He Y
Protein Pept Lett; 2019; 26(10):776-784. PubMed ID: 31208304
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of bivalent vaccines of porcine circovirus type 2 and
Lim J; Jin M; Yoon I; Yoo HS
J Vet Sci; 2022 May; 23(3):e49. PubMed ID: 35618321
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs.
Lee SI; Jeong CG; Ul Salam Mattoo S; Nazki S; Prasad Aganja R; Kim SC; Khatun A; Oh Y; Noh SH; Lee SM; Kim WI
Vaccine; 2021 Oct; 39(45):6691-6699. PubMed ID: 34538524
[TBL] [Abstract][Full Text] [Related]
14. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
[TBL] [Abstract][Full Text] [Related]
15. Field evaluation of a sing-dose bivalent vaccine of porcine circovirus type 2b and Mycoplasma hyopneumoniae.
Yang S; Ahn Y; Oh T; Cho H; Park KH; Chae C
Vet Med Sci; 2021 May; 7(3):755-765. PubMed ID: 33386664
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
Liu X; Liu Y; Zhang Y; Zhang F; Du E
BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
[TBL] [Abstract][Full Text] [Related]
17. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
Seo HW; Park SJ; Park C; Chae C
Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
[TBL] [Abstract][Full Text] [Related]
19. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.
de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA
Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602
[TBL] [Abstract][Full Text] [Related]
20. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
